|Articles|June 24, 2016
Automation in Aseptic Processing
Advertisement
Chris Procyshyn, CEO of Vanrx, sat down with BioPharm International to discuss automation in aseptic processing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
4
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
5
